<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<http://schema.org/SearchAction>
<http://www.news-medical.net/news/20121210/Boehringer-Ingelheim-to-commence-volasertib-plus-LDAC-Phase-III-study-for-AML.aspx>